no immunoreactivity of c-myc p62 was detected in tumor cells of 27 early carcinomas , while c-myc p62-positive tumor cells were observed in 51 ( 36.4 % ) of the 140 advanced carcinomas .
C0080065
c-myc p62
C0086661
c-myc